Financhill
Back

ProShares UltraPro Short Russell2000 Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
37

SRTY
ProShares UltraPro Short Russell2000

Last Price:
20.38
Seasonality Move:
-11.94%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
37
ProShares UltraPro Short Russell2000 (SRTY) is a Sell

Is ProShares UltraPro Short Russell2000 a Buy, Sell or Hold?

  • The current ProShares UltraPro Short Russell2000 [SRTY] share price is $20.39. The Score for SRTY is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • SRTY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SRTY Stock Price Chart

What is ProShares UltraPro Short Russell2000's stock price today?

  • The ProShares UltraPro Short Russell2000 share price today is $20.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRTY is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

SRTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 38.71 Sell
Chaikin Money Flow: 1092910 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.89 - 23.69) Sell
Bollinger Bands (100): (22.26 - 28.52) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

SRTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.67 Sell
20-day SMA: 22.15 Sell
50-day SMA: 22.71 Sell
200-day SMA: 28.19 Sell
8-day EMA: 21.35 Sell
20-day EMA: 22.2 Sell
50-day EMA: 23.35 Sell
200-day EMA: 29.2 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

ProShares UltraPro Short Russell2000 Earnings Growth & SRTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

ProShares UltraPro Short Russell2000 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):